Sign in

CIK 0001662579

  • Non-accelerated filer
  • Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475617627
Phone
+1 617-231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
  1. 4 Shares withheld for taxes Chief Legal Officer gave up 1,735 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief People Officer gave up 1,735 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Scientific Officer gave up 2,255 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Business Officer gave up 1,735 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Financial Officer gave up 1,301 shares (to pay taxes)
  6. 4 Grant or award Director acquired 1,687 shares (grant or award)
  7. 4 Grant or award Director acquired 1,725 shares (grant or award)
  8. 4 Grant or award Director acquired 2,108 shares (grant or award)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Grant or award Director acquired 6,617 shares (grant or award)
  12. 4 Grant or award Director acquired 6,470 shares (grant or award)
  13. 4 Grant or award Director acquired 8,089 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Grant or award Chief Financial Officer acquired 25,000 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 6 of 15 · 296 filings